Details for New Drug Application (NDA): 209646
✉ Email this page to a colleague
The generic ingredient in EPHEDRINE SULFATE is ephedrine sulfate. There are sixty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.
Summary for 209646
Tradename: | EPHEDRINE SULFATE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | ephedrine sulfate |
Patents: | 0 |
Pharmacology for NDA: 209646
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Increased Norepinephrine Activity |
Medical Subject Heading (MeSH) Categories for 209646
Suppliers and Packaging for NDA: 209646
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EPHEDRINE SULFATE | ephedrine sulfate | SOLUTION;INTRAVENOUS | 209646 | ANDA | Fresenius Kabi USA, LLC | 65219-257 | 65219-257-01 | 25 VIAL, GLASS in 1 CARTON (65219-257-01) / 1 mL in 1 VIAL, GLASS (65219-257-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/ML (50MG/ML) | ||||
Approval Date: | Aug 4, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription